Clinical study observes high financial toxicity in early-phase cancer trial participants, highlighting urgent adverse effects on patient quality of life and coping.
More than one third of EP-CT participants reported financial toxicity. Factors associated with financial toxicity and demonstrated novel associations among financial toxicity with QOL, coping, and resource concerns were identified, highlighting the need to address financial toxicity among this population.
No takes yet. Share an insight, caveat, or question.
Durbin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: